Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Juva Life Inc JUVAF

Healthcare
Juva Life Inc. is a life science company with both pharmaceutical research and development and consumer-facing operations in cannabis production and distribution. It is vertically integrated and consists of five divisions: Juva Cultivation, Juva Research, Juva Manufacturing, Juva Distribution, and Juva Retail. Juva Cultivation focuses on cultivating and distributing cannabis to medical and... see more

GREY:JUVAF - Post Discussion

Juva Life Inc > CEO Doug is a LIAR, wants his WARRANTS Exercised,in Feb 2022
View:
Post by SpaceLabs on Jan 10, 2022 12:30am

CEO Doug is a LIAR, wants his WARRANTS Exercised,in Feb 2022

His trial is dated to 2027 when he will ROOST with JUVA Insiders, share price TANKS DAILY.

The Company’s business focus is the development of safe and effective treatments targeting the global anti-inflammatory therapeutics market is estimated to reach USD $191.4 billion by 2027, as reported by Fortune Business Insights.

ALONG WAIT, not buying this DIRT.

 
Be the first to comment on this post
Juva Life Inc